Novozymes' US growth outlook dwindles

Surprisingly poor development in the US bioethanol market prompts Novozymes to downgrade its annual organic growth guidance to 3-5 percent against the prior spread of 3-6 percent.

Photo: Novozymes/ PR

Log in to read our articles

Welcome to EnergyWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles

Latest News


See all

See all